https://www.healio.com/news/allergy-asthma/20250404/dupilumab-tezepelumab-lead-biologic-initiations-for-severe-asthma
SAN DIEGO — Patients with severe asthma initiated dupilumab and tezepelumab treatment more often than other biologics between 2022 and 2023,...
dupilumabtezepelumableadbiologicinitiations
https://pubmed.ncbi.nlm.nih.gov/37272521/
Among patients with COPD who had type 2 inflammation as indicated by elevated blood eosinophil counts, those who received dupilumab had fewer exacerbations,...
dupilumabcopdtypeinflammationindicated
https://www.nice.org.uk/guidance/ta534/chapter/2-Information-about-dupilumab
Evidence-based recommendations on dupilumab (Dupixent) for treating moderate to severe atopic dermatitis in adults
information aboutdupilumabtreatingmoderatesevere